Pharmacological DVT Prophylaxis Does Not Lead to Hematoma Expansion in Intracerebral Hemorrhage with Intraventricular Extension

摘要

Background and ObjectivePatients with intracerebral hemorrhage (ICH) are at high risk for development of deep venous thrombosis (DVT). Current guidelines state that low dose subcutaneous (SQ) low-molecular weight heparin (LMWH) or unfractionated heparin (UH) may be considered at 3 to 4 days from onset. However, insufficient data exists on hematoma volume (HV) in patients with ICH before and after pharmacological DVT prophylaxis, leaving physicians with uncertainty regarding the safety of this practice.